33628366|t|Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in Mice.
33628366|a|Several interleukin (IL) members have been reported to participate in sepsis. In this study, the effects of IL-16 on sepsis-induced cardiac injury and dysfunction were examined, and the related mechanisms were detected. IL-16 expression in septic mice was first measured, and the results showed that both cardiac and serum IL-16 expression levels were increased in mice with sepsis induced by LPS or cecal ligation and puncture (CLP) compared with control mice. Then, IL-16 was neutralized, and the effects on lipopolysaccharide- (LPS-) induced cardiac injury were detected. The results showed that an anti-IL-16 neutralizing antibody (nAb) significantly reduced mortality and increased serum lactate dehydrogenase (LDH), creatine kinase myocardial bound (CK-MB), and cardiac troponin T (cTnT) levels while improving cardiac function in mice with LPS-induced sepsis. Neutralization of IL-16 also increased the activation of antioxidant pathways and the expression of antioxidant factors in septic mice while decreasing the activation of prooxidant pathways and the expression of prooxidants. Treatment with the anti-IL-16 nAb increased mitochondrial apoptosis-inducing factor (AIF) expression, decreased nuclear AIF and cleaved poly-ADP-ribose polymerase (PARP) expression, and decreased TUNEL-positive cell percentages in LPS-treated mice. Additionally, treatment with CPUY192018, the nuclear factor erythroid-2 related factor 2 (Nrf2) pathway, significantly increased mortality and reversed the above effects in mice treated with LPS and the anti-IL-16 nAb. Our results showed that the anti-IL-16 nAb regulates oxidative stress through the Nrf2 pathway and participates in the regulation of cardiac injury in septic mice. Neutralization of IL-16 may be a beneficial strategy for the prevention of cardiac injury and dysfunction in sepsis patients.
33628366	5	19	Interleukin-16	Gene	16170
33628366	63	69	Sepsis	Disease	MESH:D018805
33628366	78	108	Cardiac Injury and Dysfunction	Disease	MESH:D006331
33628366	117	160	Nuclear Factor Erythroid-2 Related Factor 2	Gene	18024
33628366	172	176	Mice	Species	10090
33628366	248	254	sepsis	Disease	MESH:D018805
33628366	286	291	IL-16	Gene	16170
33628366	295	301	sepsis	Disease	MESH:D018805
33628366	310	340	cardiac injury and dysfunction	Disease	MESH:D006331
33628366	398	403	IL-16	Gene	16170
33628366	425	429	mice	Species	10090
33628366	501	506	IL-16	Gene	16170
33628366	543	547	mice	Species	10090
33628366	553	559	sepsis	Disease	MESH:D018805
33628366	571	574	LPS	Chemical	MESH:D008070
33628366	578	583	cecal	Disease	MESH:D002429
33628366	634	638	mice	Species	10090
33628366	646	651	IL-16	Gene	16170
33628366	688	706	lipopolysaccharide	Chemical	MESH:D008070
33628366	709	712	LPS	Chemical	MESH:D008070
33628366	723	737	cardiac injury	Disease	MESH:D006331
33628366	785	790	IL-16	Gene	16170
33628366	946	964	cardiac troponin T	Gene	21956
33628366	966	970	cTnT	Gene	21956
33628366	1015	1019	mice	Species	10090
33628366	1025	1028	LPS	Chemical	MESH:D008070
33628366	1037	1043	sepsis	Disease	MESH:D018805
33628366	1063	1068	IL-16	Gene	16170
33628366	1175	1179	mice	Species	10090
33628366	1294	1299	IL-16	Gene	16170
33628366	1355	1358	AIF	Gene	26926
33628366	1390	1393	AIF	Gene	26926
33628366	1406	1432	poly-ADP-ribose polymerase	Gene	11545
33628366	1434	1438	PARP	Gene	11545
33628366	1501	1504	LPS	Chemical	MESH:D008070
33628366	1513	1517	mice	Species	10090
33628366	1548	1558	CPUY192018	Chemical	-
33628366	1564	1607	nuclear factor erythroid-2 related factor 2	Gene	18024
33628366	1609	1613	Nrf2	Gene	18024
33628366	1692	1696	mice	Species	10090
33628366	1710	1713	LPS	Chemical	MESH:D008070
33628366	1727	1732	IL-16	Gene	16170
33628366	1771	1776	IL-16	Gene	16170
33628366	1820	1824	Nrf2	Gene	18024
33628366	1871	1885	cardiac injury	Disease	MESH:D006331
33628366	1896	1900	mice	Species	10090
33628366	1920	1925	IL-16	Gene	16170
33628366	1977	2007	cardiac injury and dysfunction	Disease	MESH:D006331
33628366	2011	2017	sepsis	Disease	MESH:D018805
33628366	2018	2026	patients	Species	9606
33628366	Association	MESH:D006331	16170
33628366	Association	16170	18024
33628366	Positive_Correlation	11545	16170
33628366	Positive_Correlation	MESH:D008070	MESH:D018805
33628366	Positive_Correlation	MESH:D008070	16170
33628366	Positive_Correlation	16170	26926
33628366	Positive_Correlation	MESH:D008070	MESH:D006331
33628366	Positive_Correlation	MESH:D018805	16170
33628366	Positive_Correlation	16170	21956
33628366	Association	MESH:D002429	16170
33628366	Association	MESH:D006331	18024

